NA-Selank Amidate 10mg
Enhanced Anxiolytic Selank Analogue for Anxiety Research
NA-Selank Amidate is the N-acetylated, C-amidated form of Selank with improved stability and bioavailability. Research shows it reduces anxiety, enhances memory, and modulates immune function with a favorable safety profile.
Enhanced Anxiolytic Selank Analogue for Anxiety Research
Selank is a tuftsin-derived heptapeptide developed in Russia with anxiolytic and nootropic properties. The NA-Amidate modification protects both termini from enzymatic degradation, significantly extending its half-life and potentially enhancing its CNS effects.
As one of the most studied compounds in the longevity research space, NA-Selank has attracted sustained scientific interest across Anxiety research, Cognitive enhancement studies, Immune modulation research. Peer-reviewed evidence indicates that anxiolytic comparable to diazepam in animal models, which has positioned NA-Selank as a reference standard for researchers exploring anxiety research outcomes. The compound's selectivity and documented tolerability in preclinical models have contributed to a rapidly growing body of literature over the past decade.
NA-Selank Documented Benefits: 4 Documented Mechanisms
Anxiolytic Activity
Reduces anxiety in models comparable to benzodiazepines without sedation or dependence risk.
Cognitive Enhancement
Improves memory, attention, and learning in stress and non-stress conditions.
Immune Modulation
Regulates IL-6, IL-1β, and interferon expression to balance immune responses.
Enhanced Stability
Dual terminal protection extends half-life significantly versus unmodified Selank.
How NA-Selank Works: Molecular Mechanism & Pathway
Modified tuftsin-derived peptide with GABA-A modulatory and BDNF-enhancing activity, reducing HPA axis hyperactivity and supporting hippocampal neuroplasticity.
The 4 primary research pathways identified for NA-Selank — Anxiolytic Activity, Cognitive Enhancement, Immune Modulation — collectively point to a compound with pleiotropic activity across interconnected biological systems. Studies have further shown that enhances BDNF expression in hippocampus, reinforcing the mechanistic picture established in earlier cell-line work. Unlike single-pathway agents, NA-Selank's broad receptor engagement profile continues to generate hypotheses for novel applications beyond its originally characterized use cases.
Research Protocols & Compound Combinations
NA-Selank is routinely studied alongside NA-Selank and Semax in longevity-focused compound panels. Researchers investigating anxiety research have found that pairing compounds with complementary receptor profiles can produce additive results while keeping individual doses within well-characterized ranges. Preliminary evidence that approved drug in Russia for anxiety and depression has informed several of these multi-compound protocol designs.
Purity, Testing & Research Grade Standards
All NA-Selank research material offered through this catalog is manufactured under controlled conditions and independently verified by a third-party laboratory prior to release. Each lot undergoes High-Performance Liquid Chromatography (HPLC) analysis to confirm ≥98% purity, with identity confirmed via mass spectrometry. The accompanying Certificate of Analysis (CoA) documents the exact purity, molecular weight confirmation, and lot-specific testing date — data that should accompany any reproducible research protocol. Lyophilized powder formulation ensures maximum stability during shipping and storage at −20°C long-term or 4°C for short-term use.
◈ Key Highlights
- Anxiolytic comparable to diazepam in animal models
- Enhances BDNF expression in hippocampus
- Approved drug in Russia for anxiety and depression
Ideal For
- Anxiety research
- Cognitive enhancement studies
- Immune modulation research
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
What the Research Shows
The following data points are derived from peer-reviewed preclinical and clinical studies on NA-Selank. All studies cited in compound profiles are indexed in PubMed or published in peer-reviewed journals.
Anxiolytic comparable to diazepam in animal models
Enhances BDNF expression in hippocampus
Approved drug in Russia for anxiety and depression
Third-Party Verified Every Batch
Each vial of NA-Selank is independently tested by a third-party laboratory before fulfillment. You receive the actual CoA (Certificate of Analysis) documentation with your order.
